Blood test could guide better breast cancer treatment
NCT ID NCT07402473
Summary
This study aims to find the best pre-surgery treatment for HER2-positive early-stage breast cancer by using a tumor test (HARPS) and blood tests (ctDNA) to guide treatment choices. It will enroll 50 patients who haven't started treatment yet. The goal is to see if this personalized approach improves treatment success while reducing side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HER2-POSITIVE EARLY-STAGE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
RWJBarnabas Health - Community Medical Center
Toms River, New Jersey, 08755, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
RWJBarnabas Health - Monmouth Medical Center
Long Branch, New Jersey, 07740, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
RWJBarnabas Health - Newark Beth Israel Medical Center
Newark, New Jersey, 07112, United States
-
RWJBarnabas Health - Robert Wood Johnson University Hospital, Hamilton
Hamilton, New Jersey, 08690, United States
-
RWJBarnabas Health - Robert Wood Johnson University Hospital, Somerset
Somerville, New Jersey, 08876, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
RWJBarnabas Health - Trinitas Hospital and Comprehensive Cancer Center
Elizabeth, New Jersey, 07202, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Rutgers Cancer Institute
New Brunswick, New Jersey, 08901, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.